Shelley I White-Means
Overview
Explore the profile of Shelley I White-Means including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
White-Means S, Warren C, Osmani A
Rev Black Polit Econ
. 2022 Mar;
49(1):20-40.
PMID: 35291319
No abstract available.
2.
White-Means S, Osmani A
Int J Environ Res Public Health
. 2018 Aug;
15(9).
PMID: 30154349
Breast cancer is the most prevalent female cancer in the US. Incidence rates are similar for white and black women but mortality rates are higher for black women. This study...
3.
White-Means S, Osmani A
Inquiry
. 2017 Sep;
54:46958017727104.
PMID: 28856941
The current study explores racial/ethnic disparities in the quality of patient-provider communication during treatment, among breast cancer patients. A unique data set, Medical Expenditure Panel Survey and Experiences With Cancer...
4.
Wang J, Qiao Y, Shih Y, Jarrett-Jamison J, Spivey C, Wan J, et al.
J Manag Care Spec Pharm
. 2015 Nov;
21(11):993-1003.
PMID: 26521111
Background: The Medicare Prescription Drug, Improvement, and Modernization Act requires Part D plans to establish programs to provide medication therapy management (MTM) services starting from 2006. MTM services have been...
5.
Wang J, Qiao Y, Shih Y, Jamison J, Spivey C, Li L, et al.
Am Health Drug Benefits
. 2015 Jan;
7(6):346-58.
PMID: 25558303
Background: Previous studies have shown that there were greater racial and ethnic disparities among individuals who were ineligible for medication therapy management (MTM) services than among MTM-eligible individuals before the...
6.
Wang J, Qiao Y, Shih Y, Spivey C, Dagogo-Jack S, Wan J, et al.
J Pharm Health Serv Res
. 2014 Jul;
5(2):109-118.
PMID: 25045406
Objective: Medication therapy management (MTM) has the potential to play an instrumental role in reducing racial and ethnic disparities in health care. However, previous research has found that Blacks and...
7.
Wang J, Qiao Y, Shih Y, Wan J, White-Means S, Dagogo-Jack S, et al.
Res Social Adm Pharm
. 2013 Jun;
10(1):106-25.
PMID: 23759673
Background: Previous studies have found that racial and ethnic minorities would be less likely to meet the Medicare eligibility criteria for medication therapy management (MTM) services than their non-Hispanic White...
8.
Addo-Atuah J, Gourley D, Gourley G, White-Means S, Womeodu R, Faris R, et al.
SAHARA J
. 2012 Dec;
9(2):74-87.
PMID: 23237042
The convenience of accessing antiretroviral therapy (ART) is important for initial access to care and subsequent adherence to ART. We conducted a qualitative study of people living with HIV/AIDS (PLWHA)...
9.
Warren C, White-Means S, Wicks M, Chang C, Gourley D, Rice M
J Occup Environ Med
. 2010 Dec;
53(1):90-9.
PMID: 21187792
Objectives: To describe presenteeism, its cost burden, and comparative and interactive effects of race/ethnicity in nurses and pharmacists. Methods: Using 226 self-reports, ordinal logistic regression with marginal/interactive effects modeled 12...
10.
Wang J, Daniel Mullins C, Zuckerman I, Walker G, Suda K, Yang Y, et al.
Res Social Adm Pharm
. 2008 Sep;
4(3):206-17.
PMID: 18794032
Background: Despite the importance of equal access to prescription drugs by racial and ethnic groups, studies on access to prescription drugs have been incomprehensive. Objective: To describe the Medical Expenditure...